MORE►
adoption
Joe DePinto, head of cell, gene, and advanced therapies at McKesson [Composite photo; original: McKesson]
InspiroGene by McKesson Unveils ‘First-of-its-Kind’ Report on State of the Cell and Gene Therapy Landscape
by Lance Murray | Oct 15, 2024
Newly launched InspiroGene conducted a survey of 124 oncologists to better understand the current use of cell and gene therapies—and possible barriers to future adoption. The report proposes possible solutions to broaden access for more patients.
by Lance Murray |
Jul 24, 2023
Addison-based Credera—the consulting business of marketing group Omnicom—said the council will serve as a “collective intelligence hub” to address many different aspects of AI adoption. Founded by Credera Partner and Chief Data Scientist Vincent Yates, the council will aim to foster collaboration while guiding the responsible deployment of AI.
MORE►
